Literature DB >> 16937042

Portal hypertension--old problem, new therapeutic solutions.

Markus Peck-Radosavljevic1.   

Abstract

Portal hypertension is an old problem, but many solutions have been elaborated in recent years, mostly through international cooperation of several research groups. Ultimately, liver transplantation is a solution for all these problems but with the increasing need for liver transplantation and the lack of sufficient donor organs, there is still a high need for better conservative and interventional treatment solutions to portal hypertension. With the rapid improvements in specific therapies for chronic liver disease, especially viral hepatitis, there is hope that there will be a decreasing need for the treatment of the complications of advanced stage liver disease in future years.

Entities:  

Mesh:

Year:  2006        PMID: 16937042     DOI: 10.1007/s10354-006-0315-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  32 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.

Authors:  Carlo Merkel; Renato Marin; Paolo Angeli; Pierluigi Zanella; Martina Felder; Elisabetta Bernardinello; Giorgio Cavallarin; Massimo Bolognesi; Carlo Donada; Barbara Bellini; Pierluigi Torboli; Angelo Gatta
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

3.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

Review 4.  Review article: albumin for circulatory support in patients with cirrhosis.

Authors:  P Ginès; M Guevara; D De Las Heras; V Arroyo
Journal:  Aliment Pharmacol Ther       Date:  2002-12       Impact factor: 8.171

5.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 7.  Prevention of variceal rebleeding.

Authors:  Jaume Bosch; Juan Carlos García-Pagán
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

8.  Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding.

Authors:  Alberto Monescillo; Francisco Martínez-Lagares; Luis Ruiz-del-Arbol; Angel Sierra; Clemencia Guevara; Elena Jiménez; José Miguel Marrero; Enrique Buceta; Juan Sánchez; Ana Castellot; Mónica Peñate; Ana Cruz; Elena Peña
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 9.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

10.  A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

Authors:  D Patch; C A Sabin; J Goulis; G Gerunda; L Greenslade; C Merkel; A K Burroughs
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.